------------------------------
OMB APPROVAL
------------------------------
OMB Number 3235-0104
Expires: September 30, 1997
Estimated average burden
hours per response ....... 0.5
------------------------------
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 3
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
================================================================================
1. Name and Address of Reporting Person
Johnson & Johnson
- --------------------------------------------------------------------------------
(Last) (First) (Middle)
One Johnson & Johnson Plaza
- --------------------------------------------------------------------------------
(Street)
New Brunswick NJ 08933
- --------------------------------------------------------------------------------
(City) (State) (Zip)
================================================================================
2. Date of Event Requiring Statement (Month/Day/Year)
05/21/97
================================================================================
3. IRS or Social Security Number of Reporting Person (Voluntary)
22-01024240
================================================================================
4. Issuer Name and Ticker or Trading Symbol
Biopsys Medical, Inc. (BIOP)
================================================================================
5. Relationship of Reporting Person to Issuer
(Check all applicable)
[ ] Director [ X ] 10% Owner
[ ] Officer (give title below) [ ] Other (specify below)
--------------------------------------------------------------------
================================================================================
6. If Amendment, Date of Original (Month/Year)
================================================================================
7. Individual or Joint/Group Filing (Check applicable line)
[ X ] Form filed by One Reporting Person
[ ] Form filed by More than One Reporting Person
<PAGE>
================================================================================
Table I -- Non-Derivative Securities Beneficially Owned
================================================================================
<TABLE>
<CAPTION>
3. Ownership Form:
2. Amount of Securities Direct (D) or
1. Title of Security Beneficially Owned Indirect (I) 4. Nature of Indirect Beneficial Ownership
(Instr. 4) (Instr. 4) (Instr. 5) (Instr.5)
- ----------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
- ----------------------------------------------------------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------------------------------
==================================================================================================================================
</TABLE>
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
(Print or Type Responses)
<PAGE>
FORM 3 (continued)
Table II -- Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
================================================================================
<TABLE>
<CAPTION>
5. Owner-
3. Title and Amount of Securities ship
Underlying Derivative Security Form of
2. Date Exercisable (Instr. 4) Derivative
and Expiration Date --------------------------------- 4. Conver- Security:
(Month/Day/Year) Amount sion or Direct 6. Nature of
---------------------- or Exercise (D) or Indirect
1. Title of Date Expira- Number Price of Indirect Beneficial
Security Exer- tion of Derivative (I) Ownership
(Instr. 4) cisable Date Title Shares Security (Instr.5) (Instr. 5)
- ----------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C>
Option (see (see below) Common Stock 1,970,511 $27.55 D
(see below) below)
- ----------------------------------------------------------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------------------------------
==================================================================================================================================
</TABLE>
Explanation of Responses:
In connection with an Agreement and Plan of Merger (the "Merger Agreement")
dated as of May 21, 1997, among Johnson & Johnson (the "Reporting Person"),
Palisades Merger Corp. and Biopsys Medical, Inc. (the "Issuer"),
the Reporting Person and the Issuer entered into a Stock Option Agreement
dated as of May 21, 1997, providing for the option described above. The
option is not currently exercisable and will become exercisable only upon the
occurrence of certain events described in the Stock Option Agreement and
expires upon, or following a certain period after, the occurrence of certain
events described in the Stock Option Agreement. The number of shares of common
stock of the Issuer purchasable by the Reporting Person under the option will
be adjusted if necessary so that the number of shares purchasable by the
Reporting Person upon exercise of the option at the time of such exercise
will equal 19.9% of the outstanding shares of Common Stock of the Issuer at
such time. Prior to such exercise, the Reporting Person expressly disclaims
beneficial ownership of the shares of Common Stock of the Issuer which are
purchasable by the Reporting Person upon exercise of such option.
/s/ Peter S. Galloway June 2, 1997
- --------------------------------------------- -----------------------
**Signature of Reporting Person Date
By: Peter S. Galloway
Title: Secretary
** Intentional misstatements or omissions of facts constitute Federal Criminal
Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space provided is insufficient, See Instruction 6 for procedure.
